Trials / Completed
CompletedNCT05045443
Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 1 Year – 18 Years
- Healthy volunteers
- Not accepted
Summary
Assessment of of the biological effects of curcumin on microbiota in children with acute lymphoblastic leukemia
Detailed description
Assessment of the safety of curcumin, which is the most active constituent of the ground rhizome of the Curcuma longa plant, in children with acute lymphoblastic leukemia patients (ALL) in maintenance phase of chemotherapy through the assessment of the any reported adverse event (AE). And assessment of the curcumin effect on health by eliminating intestinal microflora dysbiosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Curcumin | Tumeric curcumin 500 mg per oral capsule of Puritans Pride company supplement |
| DIETARY_SUPPLEMENT | Standard of Care | As per institution protocol for Standard of nutritional Care |
Timeline
- Start date
- 2021-08-22
- Primary completion
- 2022-12-31
- Completion
- 2024-01-04
- First posted
- 2021-09-16
- Last updated
- 2024-01-08
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05045443. Inclusion in this directory is not an endorsement.